LifeMD (LFMDP) Net Income towards Common Stockholders (2012 - 2025)
LifeMD posted quarterly Net Income towards Common Stockholders of $19.2 million for Q4 2025, up 356.46% year-on-year from $4.2 million in Q4 2024, and up 518.69% on a QoQ basis from -$4.6 million in Q3 2025.
LifeMD (LFMDP) has 14 years of Net Income towards Common Stockholders data on file, last reported at $19.2 million in Q4 2025.
- For the quarter ending Q4 2025, Net Income towards Common Stockholders rose 356.46% year-over-year to $19.2 million; the trailing twelve-month figure through Mar 2026 stood at $15.1 million (up 169.95% YoY), and the FY2025 full-year result was $11.2 million, up 142.8% from the prior year.
- Net Income towards Common Stockholders for Q4 2025 stood at $19.2 million, up from -$4.6 million in the prior quarter.
- Across five years, Net Income towards Common Stockholders topped out at $19.2 million in Q4 2025 and bottomed at -$19.0 million in Q4 2021.
- The 5-year median for Net Income towards Common Stockholders is -$7.5 million (2023), against an average of -$7.4 million.
- The widest annual swing landed in 2021, when Net Income towards Common Stockholders tumbled 398.08%; it then jumped 356.46% in 2025.
- A 5-year view of Net Income towards Common Stockholders shows it stood at -$19.0 million in 2021, then soared by 33.03% to -$12.7 million in 2022, then surged by 64.53% to -$4.5 million in 2023, then slumped by 65.94% to -$7.5 million in 2024, then jumped by 356.46% to $19.2 million in 2025.
- The last three Net Income towards Common Stockholders figures came in at $19.2 million (Q4 2025), -$4.6 million (Q3 2025), and $455210.0 (Q2 2025), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Net Income (Qtr) |
|---|---|---|---|---|---|
| 1 | Veeva Systems | 30.85 Bn | 24.28 Bn | 622.47 Mn | 244.20 Mn |
| 2 | BrightSpring Health Services | 12.29 Bn | 11.41 Bn | 482.22 Mn | 74.33 Mn |
| 3 | Healthequity | 7.80 Bn | 7.48 Bn | 256.31 Mn | 69.42 Mn |
| 4 | Hinge Health | 4.82 Bn | 4.51 Bn | 154.23 Mn | 34.01 Mn |
| 5 | Doximity | 4.21 Bn | 3.46 Bn | 125.97 Mn | 19.11 Mn |
| 6 | Waystar Holding | 4.18 Bn | 4.03 Bn | 268.04 Mn | 43.32 Mn |
| 7 | 10x Genomics | 3.78 Bn | 3.24 Bn | 106.18 Mn | -13.47 Mn |
| 8 | Privia Health | 2.65 Bn | 2.28 Bn | 595.71 Mn | 3.71 Mn |
| 9 | Omnicell | 1.95 Bn | 1.78 Bn | 140.36 Mn | 11.41 Mn |
| 10 | LifeMD | - | - | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | 19.19 Mn |
| Sep 30, 2025 | -4.58 Mn |
| Jun 30, 2025 | 455,210.00 |
| Mar 31, 2025 | -960,341.00 |
| Dec 31, 2024 | -7.48 Mn |
| Sep 30, 2024 | -5.43 Mn |
| Jun 30, 2024 | -7.65 Mn |
| Mar 31, 2024 | -7.54 Mn |
| Dec 31, 2023 | -4.51 Mn |
| Sep 30, 2023 | -6.90 Mn |
| Jun 30, 2023 | -7.51 Mn |
| Mar 31, 2023 | -4.79 Mn |
| Dec 31, 2022 | -12.71 Mn |
| Sep 30, 2022 | -8.06 Mn |
| Jun 30, 2022 | -13.80 Mn |
| Mar 31, 2022 | -14.08 Mn |
| Dec 31, 2021 | -18.98 Mn |
| Sep 30, 2021 | -14.35 Mn |
| Jun 30, 2021 | -16.83 Mn |
| Mar 31, 2021 | -11.60 Mn |
| Dec 31, 2020 | -32.25 Mn |
| Sep 30, 2020 | -24.20 Mn |
| Jun 30, 2020 | -3.38 Mn |
| Mar 31, 2020 | -2.39 Mn |
| Dec 31, 2019 | -711,547.00 |
| Sep 30, 2019 | -943,804.00 |
| Jun 30, 2019 | -962,990.00 |
| Mar 31, 2019 | -733,563.00 |
| Jun 30, 2018 | -10,192.00 |
| Mar 31, 2018 | 925,738.00 |
| Dec 31, 2017 | -92,055.00 |
| Sep 30, 2017 | -651,891.00 |
| Jun 30, 2017 | 154,825.00 |
| Mar 31, 2017 | 26,807.00 |
| Dec 31, 2016 | -741,056.00 |
| Sep 30, 2016 | -217,696.00 |
| Jun 30, 2016 | -156,382.00 |
| Mar 31, 2016 | -108,159.00 |
| Dec 31, 2015 | -147,989.00 |
| Sep 30, 2015 | 3,519.00 |
| Jun 30, 2015 | -25,328.00 |
| Mar 31, 2015 | -2,634.00 |
| Dec 31, 2014 | -148,437.00 |
| Sep 30, 2014 | -108,204.00 |
| Jun 30, 2014 | -75,805.00 |
| Mar 31, 2014 | -145,239.00 |
| Dec 31, 2013 | -75,854.00 |
| Sep 30, 2013 | -143,666.00 |
| Jun 30, 2013 | -20,154.00 |
| Mar 31, 2013 | -45,787.00 |
| Dec 31, 2012 | -75,464.00 |
| Sep 30, 2012 | -163,641.00 |
| Jun 30, 2012 | -191,142.00 |
| Mar 31, 2012 | -32,593.00 |